| 1 |
35182674 | siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin. | 2022 May 5 |
2 |
| 2 |
35398618 | Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration. | 2022 May |
3 |
| 3 |
32700607 | Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells. | 2021 |
1 |
| 4 |
33313950 | Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG. | 2021 Feb |
1 |
| 5 |
34168463 | Epigenetic Mechanism of Enrichment of A549 Lung Cancer Stem Cells with 5-Fu. | 2021 |
1 |
| 6 |
34400945 | Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549. | 2021 Winter |
1 |
| 7 |
31974865 | DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. | 2020 Apr |
1 |
| 8 |
32710593 | Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition. | 2020 Nov |
3 |
| 9 |
29574322 | Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells. | 2018 Aug |
1 |
| 10 |
30288106 | S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism. | 2018 |
1 |
| 11 |
27884977 | NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer. | 2017 Feb 28 |
2 |
| 12 |
29169370 | Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop. | 2017 Nov 23 |
1 |
| 13 |
26801672 | NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. | 2016 Jul |
1 |
| 14 |
27105520 | Cisplatin induces stemness in ovarian cancer. | 2016 May 24 |
3 |
| 15 |
27881153 | Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma. | 2016 Nov 24 |
1 |
| 16 |
24475288 | Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells. | 2014 |
2 |
| 17 |
25158233 | Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas. | 2014 Aug 25 |
2 |
| 18 |
23625774 | MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death. | 2013 Dec |
1 |
| 19 |
22473773 | Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. | 2012 Sep |
1 |
| 20 |
22847005 | Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. | 2012 Sep 21 |
1 |
| 21 |
23221432 | Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells. | 2012 |
2 |
| 22 |
21342274 | Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. | 2011 Sep |
4 |